Loop diuretics, and in particular furosemide, are the most effective agents for the management of signs and symptoms of fluid overload in patients with heart failure (HF). Indeed, through their ...

In the Diuretic Optimization Strategies Evaluation (DOSE), the vexing issue of optimal administration of furosemide in patients with acute decompensated heart failure was tackled. In addition to the ...

BURLINGTON, Mass., Oct. 8, 2025 /PRNewswire/ -- SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ® ONYU (furosemide ...

CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...

JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and ...

Over time, the retention of sodium leads to crackles, peripheral edema, hepatomegaly with ascites, increased blood volume, and increased cardiac filling pressures. Although diuretics do not directly ...

The MarketWatch News Department was not involved in the creation of this content. Addressing a Leading Cause of Hospitalization in Older Adults with Heart Failure BURLINGTON, Mass., Feb. 9, 2026 ...